A study in Anesthesiology suggests a new target for pain control in patients who develop chronic pain after surgery. The target, spinal cathepsin G (CTSG), is a pro-nociceptive mediator in both an animal model and human study. The research points to the potential for inhibiting CTSG through an inhibitor.

READ FULL ARTICLE Curated publisher From www.hcplive.com